Identifying novel biomarkers associated with bladder cancer treatment outcomes
Bladder cancer is a complex disease with variable prognosis. Recent investigations into the molecular landscape of bladder cancer have revealed frequent genetic alterations and molecular subtypes with therapeutic implications. Consequently, a shift toward personalized treatment of bladder cancer is...
Main Authors: | Peris R. Castaneda, Dan Theodorescu, Charles J. Rosser, Michael Ahdoot |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1114203/full |
Similar Items
-
Urinary bladder cancer: biomarkers and target therapy, new era for more attention
by: Amrallah A. Mohammed, et al.
Published: (2016-12-01) -
Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling
by: Jin-Fen Xiao, et al.
Published: (2021-09-01) -
CD44 in Bladder Cancer
by: Jason Duex, et al.
Published: (2024-03-01) -
Biomarker-Oriented Therapy in Bladder and Renal Cancer
by: Mathijs P. Scholtes, et al.
Published: (2021-03-01) -
Bioinformatics Analysis Identifying Key Biomarkers in Bladder Cancer
by: Chuan Zhang, et al.
Published: (2020-04-01)